Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this trial is to determine if adjuvant therapy with axitinib will prevent or delay the recurrence of renal cell cancer after surgery to remove the primary tumor in high risk patients.
Epistemonikos ID: 044c1c775185faa4daed412f4bbe53e0dfcc04f8
First added on: Jul 17, 2020